In the competitive landscape of biopharmaceutical development, the importance of reliable preclinical services in New York cannot be overstated. As the first crucial step in the drug development pathway, preclinical research helps validate drug candidates before reaching clinical trials. At InfinixBio, we offer specialized, full-service preclinical solutions designed to expedite your journey from discovery to market.
Preclinical services play a pivotal role in drug development, providing essential data on safety, efficacy, and mechanistic understanding. Companies seeking to navigate the complexities of preclinical services in New York benefit from tailored solutions that respond to their unique project requirements.
Assay Development & Sample Testing: Crucial for identifying and validating the biological activity of drug candidates, our assay development encompasses both in vitro and in vivo models.
Target Identification and Validation: We support your drug discovery efforts by validating biological targets that hold promise for therapeutic intervention.
Dose Escalating Studies: Our methods in conducting single ascending and multiple dose studies help in determining appropriate dosage for clinical development.
Pharmacokinetic (PK) and Pharmacodynamics (PD) Studies: Comprehensive PK/PD analysis ensures that your drug’s behavior in the body is well understood, aiding in effective dosing strategies.
Immunogenicity Testing (ADA Analysis): Understanding the immune response to therapeutic proteins is critical. We provide thorough immunogenicity assessments, including Gene Therapy Immunogenicity studies.
Partnering with InfinixBio offers numerous advantages, ensuring your project’s success:
A critical component of preclinical services in New York is toxicology studies, which are essential for assessing the safety profile of drug candidates. For detailed insights, you can explore the significance of these studies in our article about toxicology studies in New York.
Preclinical services encompass the research and testing conducted to assess the safety and efficacy of drug candidates before commencing human trials. They mitigate risks and provide foundational data vital for regulatory submissions.
At InfinixBio, we implement rigorous quality control measures aligned with GxP standards (GLP, GCP, GMP) to ensure compliance throughout the preclinical development process.
Yes, InfinixBio has extensive experience across a broad spectrum of therapeutic areas, including but not limited to oncology, immunology, and neurology.
Choosing the right partner for preclinical services in New York is crucial for the success of your drug development project. InfinixBio is dedicated to providing exceptional preclinical research services that enhance your ability to deliver effective therapies to the market.
For more information on how we can assist you, please contact us today. Let’s collaborate to bring your vision to fruition!
Our experienced lab team is here to help. Reach out today to learn more.